ab661 を使用した論文を発表された方は、こちらまでお知らせください。データシートに掲載させていただきます。

ab661 は 4 報の論文で使用されています。

  • Kim JK  et al. Synthetic peptides containing ITIM-like domains block expression of inflammatory mediators and migration/invasion of cancer cells through activation of SHP-1 and PI3K. Cancer Invest 30:364-71 (2012). PubMed: 22571339
  • Lee SM  et al. Synthetic peptides containing ITIM-like sequences of IREM-1 (CD300F) differentially regulate MyD88 and TRIF-mediated TLR signalling through activation of SHP and/or PI3K. Clin Exp Immunol 167:438-46 (2012). WB, IP ; Human . PubMed: 22288587
  • Lee SM  et al. CD300F blocks both MyD88 and TRIF-mediated TLR signaling through activation of Src homology region 2 domain-containing phosphatase 1. J Immunol 186:6296-303 (2011). IP ; Human . PubMed: 21536801
  • Lee SM  et al. Synthetic peptides containing ITIM-like sequences of IREM-1 inhibit BAFF-mediated regulation of interleukin-8 expression and phagocytosis through SHP-1 and/or PI3K. Immunology 134:224-33 (2011). IP ; Human . PubMed: 21896016

Please note: All products are "FOR RESEARCH USE ONLY AND ARE NOT INTENDED FOR DIAGNOSTIC OR THERAPEUTIC USE"